Aristo Bio-Tech And Lifescience Limited

NSE: ARISTO · Unclassified

₹99.10+4.87%06 Nov 2026

Ask the data

Instant answers about Aristo Bio-Tech And Lifescience Limited — computed from its filings, no language model

Market cap₹67 cr

Current price₹99.10

High / Low₹146 / ₹75

P/E9.4

P/B1.52

Book value₹65.4

ROE16.1%

ROCE17.0%

Debt / equity0.80

Dividend yield—

EPS (TTM)₹10.55

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY23	FY25	FY26
Revenue	217.9	318.1	363.7
EBITDA	8.7	9.3	16.1
Operating margin	4.0%	2.9%	4.4%
Interest	2.8	1.7	3.9
Depreciation	1.5	2.6	2.9
Profit before tax	4.7	5.5	9.7
Tax	1.2	1.4	2.5
Net profit	3.6	4.1	7.2
EPS ₹	6.72	5.97	10.55
Operating cash flow	-2.8	10.0	8.4
Capex	2.8	5.1	2.6
Dividend paid	0.0	0.3	0.0
Total assets	99.8	140.6	155.2
Equity	30.2	37.3	44.5

Half-yearly performance

last 7 half years · ₹ crore

showing latest 6 of 7 periods

	H1 FY23*	H2 FY23	H1 FY24	H1 FY25	H2 FY25	H1 FY26	H2 FY26
Revenue	129.1	88.8	132.8	214.2	104.0	256.4	107.3
Operating profit	5.1	3.6	5.2	8.2	1.1	7.9	8.2
Operating margin	3.9%	4.1%	3.9%	3.8%	1.1%	3.1%	7.6%
Other income	0.0	0.3	0.1	0.2	0.2	0.1	0.4
Interest	0.8	2.0	1.0	1.0	0.6	1.0	2.9
Depreciation	0.7	0.8	0.8	1.3	1.3	1.5	1.5
Profit before tax	3.6	1.1	3.6	6.1	-0.6	5.5	4.2
Tax	1.0	0.1	1.0	1.5	-0.1	1.4	1.1
Net profit	2.6	1.0	2.6	4.5	-0.5	4.2	3.0
EPS ₹	4.94	1.78	3.78	6.69	-0.72	6.12	4.43
Revenue YoY	—	—	2.9%	61.2%	—	19.8%	3.2%
Profit YoY	—	—	0.4%	77.0%	—	-8.4%	—

Returns & margins

trailing-twelve-month, per half year

	H2 FY23	H1 FY24	H2 FY25	H1 FY26	H2 FY26
ROE	11.8%	11.8%	10.9%	8.9%	16.1%
ROCE	14.2%	14.7%	12.0%	8.6%	17.0%
Net margin	1.6%	1.6%	1.3%	1.0%	2.0%
EBITDA margin	4.0%	4.0%	2.9%	2.5%	4.4%
Debt / equity	0.75	0.75	0.59	0.84	0.80
Interest coverage	2.72	2.57	4.30	4.05	3.49
Asset turnover	2.18	2.22	2.26	1.44	2.34

Balance sheet

equity vs borrowings over time · ₹ crore

	MAR '23	SEP '24	MAR '25	SEP '25	MAR '26
Share capital	6.8	6.8	6.8	6.8	6.8
Other equity / reserves	23.4	31.4	30.5	34.7	37.7
Total equity	30.2	38.2	37.3	41.5	44.5
Borrowings	22.5	20.3	21.9	34.7	35.4
Current liabilities	59.5	176.2	95.6	200.5	103.1
Non-current liabilities	10.2	8.9	7.7	8.1	7.6
Total assets	99.8	223.3	140.6	250.1	155.2
Property, plant & equipment	15.6	23.2	23.9	24.1	23.6
Investments	0.0	0.0	0.0	0.0	0.2
Inventories	30.8	44.7	47.4	45.8	63.2
Receivables	44.6	142.3	56.2	154.4	54.7
Cash & equivalents	1.9	0.8	1.1	2.1	2.6

Cash flow

annual · ₹ crore · line = free cash flow

	FY23	FY25	FY26
Cash from operations	-2.8	10.0	8.4
Cash from investing	-3.8	-5.2	-3.0
Cash from financing	8.0	-4.4	-4.0
Capex	2.8	5.1	2.6
Free cash flow	-5.6	4.9	5.8
Dividends paid	0.0	0.3	0.0

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹23.6 cr15%

Investments

₹0.2 cr0%

Inventories

₹63.2 cr41%

Receivables

₹54.7 cr35%

Cash & equivalents

₹2.6 cr2%

Other assets

₹10.8 cr7%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Aristo Bio-Tech And Lifescience Limited	67	99.10	9.4	1.52	16.1%

StoxGud checklist: Neutral setup · 6/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-3.8%

6 months-23.8%

1 year-23.2%

3Y CAGR+5.6%

5Y CAGR—

10Y CAGR—

50-day avg₹98.25

200-day avg₹112.87

RSI (14)61

FAQs

What is the share price of Aristo Bio-Tech And Lifescience Limited?

Aristo Bio-Tech And Lifescience Limited (ARISTO) closed at ₹99.10 on NSE on 06 Nov 2026.

What is the market cap of Aristo Bio-Tech And Lifescience Limited?

₹67 crore at the latest close.

What is the P/E ratio of Aristo Bio-Tech And Lifescience Limited?

9.4, on trailing-twelve-month earnings from its filings.

How fast is Aristo Bio-Tech And Lifescience Limited growing?

Aristo Bio-Tech And Lifescience Limited: Latest-half-year revenue is up 3.2% year on year.

How profitable is Aristo Bio-Tech And Lifescience Limited?

On a trailing-twelve-month basis return on equity is 16.1%, return on capital employed 17.0%, operating margin 4.4%, net margin 2.0%.

How much debt does Aristo Bio-Tech And Lifescience Limited have?

Aristo Bio-Tech And Lifescience Limited is moderately geared: debt to equity is 0.80 with borrowings of ₹35 cr against cash of ₹3 cr (balance sheet of 2026-03-31). Operating profit covers interest 3.5 times.

Financials parsed from Aristo Bio-Tech And Lifescience Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Half-yearly from H1 FY23, annual from FY23, balance sheet from Mar '23. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.